DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Spherics
Spherics focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles.
Spherics
Mansfield, MA
